In addition, combination therapy and antibodies that target the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) are used to treat selected patients with colorectal cancer [16,17]. This evidence concerns the gene EGFR and colorectal cancer.